cdr

Hot Keywords
Drug Resistance Mechanisms Epigenetic Resistance in Cancer Therapy Biomarkers Pharmacogenetics of Cancer Liquid Biopsy Targeted Cancer Therapy Non-coding RNAs Kinase Inhibitors ABC Transporters

Top
Article Processing Charges

Cancer Drug Resistance (CDR) is an open access journal. Before March 31, 2022, there are no article processing charges for papers accepted for publication after peer review. OAE subsidizes and helps authors publish their manuscripts totally free. For more details, please refer to OAE Publication Fees.

Copyright © 2021 OAE Publishing Inc. All Rights Reserved.